Search for: "M.D. Janet Woodcock" Results 41 - 47 of 47
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Dec 2010, 10:48 am by Gene Quinn
“After careful review of the clinical data, we are recommending that the breast cancer indication for Avastin® be removed based on evidence from four independent studies,” Janet Woodcock, M.D., director of the FDA’s Center for Drug Evaluation and Research. [read post]
20 Jul 2021, 3:21 pm by Dan Flynn
In FDA Voices, Janet Woodcock, M.D., Acting Commissioner of Food and Drugs, and Yiannas, Deputy Commissioner for Food Policy and Response provided details. [read post]
1 Apr 2012, 8:58 am by FDABlog HPM
  It would also give the OGD Director (currently Keith Webber, Ph.D.) direct reporting to the CDER Director (currently Janet Woodcock, M.D.). [read post]
31 May 2022, 12:39 pm by Ana Popovich
After a February recall of powdered infant formula manufactured in an Abbott Laboratories facility in Sturgis, Michigan, parents across the U.S. have struggled to find formulas and been confronted by empty shelves. [read post]
22 Dec 2008, 5:30 pm
“These tainted weight loss products pose a great risk to public health because they contain undeclared ingredients and, in some cases, contain prescription drugs in amounts that greatly exceed their maximum recommended dosages,” said Janet Woodcock, M.D., director, Center for Drug Evaluation and Research, FDA. [read post]
9 Apr 2016, 8:58 am by Schachtman
  The PSC pointed to the specific causation opinions of a clinical cardiologist, Ra-Id Abdulla, M.D., who proffered dubious differential etiologies, ruling in Zoloft as a cause of individual children’s birth defects, despite his inability to rule out truly known and unknown causes in the differential reasoning. [read post]
9 Mar 2013, 7:33 pm by Mark Zamora
On my blog I've been writing on the New England Compounding Pharmacy tragedy since the news of the fateful recall started. [read post]